Literature DB >> 24655110

BCS1L gene mutation causing GRACILE syndrome: case report.

Çiğdem Seher Kasapkara1, Leyla Tümer, Fatih Suheyl Ezgü, Aynur Küçükçongar, Alev Hasanoğlu.   

Abstract

GRACILE syndrome is a rare autosomal recessive disease characterized by fetal growth retardation, Fanconi type aminoaciduria, cholestasis, iron overload, profound lactic acidosis, and early death. It is caused by homozygosity for a missense mutation in the BCS1L gene. The BCS1L gene encodes a chaperone responsible for assembly of respiratory chain complex III. Here we report that a homozygous mutation c.296C > T (p.P99L), in the first exon of BCS1L gene found in an affected 2-month-old boy of asymptomatic consanguineous parents results in GRACILE syndrome. This genotype is associated with a severe clinical presentation. So far no available treatments have changed the fatal course of the disease, and the metabolic disturbance responsible is still not clearly identified. Therefore, providing prenatal diagnosis in families with previous affected infants is of major importance. Mitochondrial disorders are an extremely heterogeneous group of diseases sharing, in common, the fact that they all ultimately impair the function of the mitochondrial respiratory chain. A clinical picture with fetal growth restriction, postnatal lactacidosis, aminoaciduria, hypoglycemia, coagulopathy, elevated liver enzymes, and cholestasis should direct investigations on mitochondrial disorder.

Entities:  

Keywords:  Cholestasis; Fanconi type aminoaciduria; growth retardation; iron overload; profound lactic acidosis

Mesh:

Substances:

Year:  2014        PMID: 24655110     DOI: 10.3109/0886022X.2014.900422

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  7 in total

1.  Mitochondrial Cytochrome c Oxidase Defects Alter Cellular Homeostasis of Transition Metals.

Authors:  Michele Brischigliaro; Denis Badocco; Rodolfo Costa; Carlo Viscomi; Massimo Zeviani; Paolo Pastore; Erika Fernández-Vizarra
Journal:  Front Cell Dev Biol       Date:  2022-05-19

2.  Renal manifestations of primary mitochondrial disorders.

Authors:  Josef Finsterer; Fulvio Alexandre Scorza
Journal:  Biomed Rep       Date:  2017-04-12

3.  Characterising a homozygous two-exon deletion in UQCRH: comparing human and mouse phenotypes.

Authors:  Silvia Vidali; Raffaele Gerlini; Kyle Thompson; Jill E Urquhart; Jana Meisterknecht; Juan Antonio Aguilar-Pimentel; Oana V Amarie; Lore Becker; Catherine Breen; Julia Calzada-Wack; Nirav F Chhabra; Yi-Li Cho; Patricia da Silva-Buttkus; René G Feichtinger; Kristine Gampe; Lillian Garrett; Kai P Hoefig; Sabine M Hölter; Elisabeth Jameson; Tanja Klein-Rodewald; Stefanie Leuchtenberger; Susan Marschall; Philipp Mayer-Kuckuk; Gregor Miller; Manuela A Oestereicher; Kristina Pfannes; Birgit Rathkolb; Jan Rozman; Charlotte Sanders; Nadine Spielmann; Claudia Stoeger; Marten Szibor; Irina Treise; John H Walter; Wolfgang Wurst; Johannes A Mayr; Helmut Fuchs; Ulrich Gärtner; Ilka Wittig; Robert W Taylor; William G Newman; Holger Prokisch; Valerie Gailus-Durner; Martin Hrabě de Angelis
Journal:  EMBO Mol Med       Date:  2021-11-08       Impact factor: 14.260

Review 4.  Mitochondrial Neurodegeneration.

Authors:  Massimo Zeviani; Carlo Viscomi
Journal:  Cells       Date:  2022-02-11       Impact factor: 6.600

5.  Clinical and diagnostic characteristics of complex III mitopathy due to novel BCS1L gene mutation in a Saudi patient.

Authors:  Mansour Al Qurashi; Ahmed Mustafa; Syed Sameer Aga; Abrar Ahmad; Abdellatif El-Farra; Aiman Shawli; Mohammed Al Hindi; Mohammed Hasosah
Journal:  BMC Med Genomics       Date:  2022-03-19       Impact factor: 3.063

Review 6.  Nuclear gene mutations as the cause of mitochondrial complex III deficiency.

Authors:  Erika Fernández-Vizarra; Massimo Zeviani
Journal:  Front Genet       Date:  2015-04-09       Impact factor: 4.599

7.  Modelling of BCS1L-related human mitochondrial disease in Drosophila melanogaster.

Authors:  Michele Brischigliaro; Elena Frigo; Samantha Corrà; Cristiano De Pittà; Ildikò Szabò; Massimo Zeviani; Rodolfo Costa
Journal:  J Mol Med (Berl)       Date:  2021-07-17       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.